PEPTARA LABS
Get Started
Peptara Labs Tirzepatide 20mg vial thumbnail

Dual agonist

Tirzepatide

Studied in Phase 3 trials for up to 22.5% body-weight reduction

22.5%

Average weight loss

SURMOUNT-1 Phase 3 Trial

$92 USDWas $185 USD

Flat $35 tracked shipping20mg per vial

1vial

$92 USD

$92.00 per vial

Add 2 more, unlock 19%

Single vials are sold out. Tirzepatide is available in the Lumen research stack. See the stack

Certificate of analysis results for Tirzepatide, lot TIRZ-260420-A
TestResultVerdict
Purity99.31%PASS
IdentityConfirmedPASS
SterilityNo growthPASS
Endotoxin<1 EU/VialPASS
Heavy metals + fentanylNot detectedPASS
LOT TIRZ-260420-AView certificate
Peptara Labs Tirzepatide 20mg vial
Unavailable (Sold Out)

Shipping, delivery and guarantee terms

Shipping
Flat $35, tracked worldwide to supported markets
Delivery
5 to 10 business days, guaranteed
Payment
Card, bank transfer, or crypto · All sales final except a purity failure
Included
60-day money-back guarantee · Third-party batch COA

The short answer

What is tirzepatide?

Tirzepatide is a dual GIP and GLP-1 receptor agonist studied as a once-weekly peptide for weight loss. In the Phase 3 SURMOUNT-1 trial, the 15 mg arm reached a group mean of up to about 22.5 percent body-weight reduction over 72 weeks (Jastreboff et al., NEJM 2022). The brand drug is FDA-approved as Mounjaro and Zepbound; research-grade tirzepatide, including ours, is not an approved medicine and is sold for research purposes only.

For what the trials actually used, see the tirzepatide dosage schedule and the results timeline measured over 72 weeks.

Comparing the GLP-1 class

How does retatrutide compare with semaglutide and tirzepatide?

Semaglutide is a single GLP-1 receptor agonist, tirzepatide a GIP and GLP-1 dual agonist, and retatrutide a triple agonist adding glucagon. The three were measured in separate trials with different designs and populations, never head to head, so the honest comparison is trial by trial rather than a ranking. Two research-based comparisons:

Ozempic, Wegovy, and Mounjaro are FDA-approved medications. Research-grade peptides, including ours, are not FDA-approved and are sold for research purposes only. This is education, not medical advice or a treatment claim.

The Science

Dual-Agonist Technology

Tirzepatide activates two metabolic receptor pathways: GLP-1 and GIP. Whether that dual mechanism outperforms a single agonist has not been settled by a head-to-head obesity trial in the published record; the comparisons available come from separate trials.

GLP-1 Receptor

Appetite Suppression

GLP-1 receptor signaling is described as reducing hunger signaling, increasing satiety and slowing gastric emptying.

GIP Receptor

Fat Metabolism

GIP receptor signaling is described as modulating insulin sensitivity, lipid handling and glucose control.

Clinical Data

Clinical Trial Results

22.5%

Mean body-weight reduction, 15 mg arm

SURMOUNT-1, 72 weeks

89%

Achieved 5%+ Loss

of participants

2,539

Trial Participants

SURMOUNT-1

Data from SURMOUNT-1 Phase 3 clinical trial, published in The New England Journal of Medicine. Results represent participants receiving the 15mg maintenance dose. Individual results may vary.

A Well-Studied Compound

The brand drug tirzepatide is FDA-approved as Mounjaro (for Type 2 diabetes) and Zepbound (for weight management); research-grade tirzepatide, including ours, is not an FDA-approved product. The compound has been studied in clinical trials with over 20,000 participants, with reported side effects documented across those trials.

Doses as studied

What doses did the tirzepatide trials study?

SURMOUNT-1 tested three once-weekly maintenance doses, 5 mg, 10 mg, and 15 mg, against placebo over 72 weeks, with each arm reached by gradual step-up from a low starting dose (Jastreboff et al., NEJM 2022). The dosing chart below is a record of what that trial measured, not a target for any one person.

Once-weekly maintenance doseReported mean weight change at 72 weeksSource
Placeboabout -3 percentJastreboff et al., NEJM 2022
5 mgabout -15 percentJastreboff et al., NEJM 2022
10 mgabout -19.5 percentJastreboff et al., NEJM 2022
15 mgup to about -22.5 percentJastreboff et al., NEJM 2022

The trials reported these doses in milligrams. When a lyophilized vial is reconstituted, the reading in units on a syringe depends on how much bacteriostatic water is added, which is a concentration calculation rather than a dose. The reconstitution calculator does that math, and the tirzepatide dosage page covers the step-up schedule the studies used. How a compound is administered is a question for a licensed clinician.

Comparison

Semaglutide vs tirzepatide: how do they compare?

Tirzepatide is a dual GIP and GLP-1 receptor agonist; semaglutide is a single GLP-1 agonist. Across separate Phase 3 obesity trials, semaglutide reached about 15 percent mean body-weight reduction in STEP 1 (Wilding et al., NEJM 2021) and tirzepatide reached up to about 22.5 percent in SURMOUNT-1 (Jastreboff et al., NEJM 2022).

CompoundReceptor targetsTop reported weight lossSource
SemaglutideGLP-1about 15 percentWilding et al., NEJM 2021
TirzepatideGIP and GLP-1up to about 22.5 percentJastreboff et al., NEJM 2022

Those numbers come from different trials with different designs and populations, so the gap between them is not a measured head-to-head difference. The one direct comparison, SURPASS-2, was run in adults with type 2 diabetes rather than obesity and reported larger reductions in blood sugar and body weight with tirzepatide (Frías et al., NEJM 2021). For the dose-by-dose picture, see tirzepatide vs Ozempic and semaglutide dosage.

Compounded, brand, research-grade

What is compounded tirzepatide?

Tirzepatide reaches people in three different forms that are not interchangeable. The brand drug is FDA-approved under two names: Mounjaro, for type 2 diabetes, and Zepbound, for weight management. Compounded tirzepatide is prepared by licensed compounding pharmacies and dispensed on a prescription, a channel that saw wide use during the branded shortage, and it is a different regulatory category from the brand product.

Research-grade tirzepatide, including ours, is laboratory material sold for research purposes only. It is not an approved medicine, not a compounded prescription, and not a branded drug. For how the three differ, see the compounded tirzepatide explainer.

Research Timeline

What the studies measured, and when

Research timeline

What the studies measured, and when

The trial

SURMOUNT-1 tested three once-weekly maintenance doses, 5 mg, 10 mg and 15 mg, against placebo over 72 weeks (Jastreboff et al., NEJM 2022; doi:10.1056/NEJMoa2206038; PMID 35658024).

Escalation

Each arm was reached by gradual escalation rather than started at its maintenance dose, which is the standard approach for reducing early gastrointestinal effects in this class.

72 weeks

The 15 mg arm reached up to about 22.5 percent mean weight loss, with smaller reductions at 10 mg and 5 mg (Jastreboff et al., 2022).

Approval status

The brand drug is FDA-approved as Mounjaro and Zepbound. Research-grade tirzepatide, including ours, is not an approved medicine.

Your Kit

What's Included

What ships with the Tirzepatide order: peptide vial, bacteriostatic water and container

$92 USD

Flat $35 shipping · All sales final

Single vials are sold out. Tirzepatide is available in the Lumen research stack. See the stack

Tirzepatide 20mg Vial

20mg per vial · Lyophilized powder, sealed vial

Study Protocol Reference

Educational ranges and titration schedules reported in published studies. Not a prescription; consult a licensed physician.

Worldwide Shipping

5 to 10 business days, guaranteed

Ongoing order support

Direct team access

Your kit includes the vials and bacteriostatic water. Insulin syringes ship to select delivery regions; where they can't ship, we send a same-day sourcing link. A printed reference guide ships with every order.

Research dose ranges
Reconstitution calculator
WhatsApp support
60-day money back

Traveling with your order

Freeze-dried vials travel well; reconstituted vials travel cold. Rules vary by country. Share your dates when you order.

Why your vials arrive plain

Unlabeled on purpose: discreet, and standard for research-grade material. Match a batch to its certificate with your order number. See the COA page.

Verified orders

What buyers said about their Tirzepatide order

5.00 · 12 reviews from orders containing this vial. Published word for word.

★★★★★

i had been burned by a supplier who shipped the wrong strength last year and this time everything matched exactly what was on my order confirmation. no confusion, no back and forth over what should have arrived versus what actually did

Tam - Hue

Verified order · Tirzepatide, CJC-1295 / Ipamorelin · Aug 07, 2026

★★★★★

this was my second run through and honestly the packaging barely changed between orders in a good way, same tray layout, same tape placement down to the millimeter. whatever process they have running is clearly not improvised week to week

Anon - Boise, ID

Verified order · Tirzepatide, MOTS-c · Jul 26, 2026

★★★★★

i was planning to wait one more month before trying a new supplier but a sister in a group chat mentioned them and the timing just worked out better than expected. first order went through cleanly with nothing missing from what was listed

Kai - Hoi An

Verified order · Tirzepatide · Jul 21, 2026

★★★★★

arrived wednesday which i think was slightly ahead of the quoted window but i am not going to quibble about it. box was flat and undamaged, tape job straight down the middle like a factory seal rather than someone just slapping three strips on crookedly

Anon - Cần Thơ

Verified order · Retatrutide, Tirzepatide · Jul 11, 2026

★★★★★

i had put this on my list to try for a while and only got around to ordering when a colleague at work mentioned they had already been through two rounds. the timing worked out fine and nothing about the first delivery was off in any way

Lan - Da Nang

Verified order · Tirzepatide, CJC-1295 / Ipamorelin · Jul 04, 2026

★★★★★

second order now and what stood out this time was the insert card. last one had my street number off by two digits which i only caught because i double checked before binning it, this one is spot on. small thing but it tells me someone actually proofed things instead of just hitting send

Noor - Las Vegas, NV

Verified order · Tirzepatide · Jun 20, 2026

Read all 117 order reviews

Our Guarantee

We Stand Behind Our Quality.

Peptara Labs supplies research-grade Tirzepatide. The brand drugs Mounjaro and Zepbound are FDA-approved; research-grade tirzepatide, including ours, is not an FDA-approved product. We stand behind our product quality, verified by a certificate of analysis on every batch.

60-Day Money Back Guarantee

Test it at any lab, or your money back

Send any vial to an independent lab within 60 days of delivery. If it does not test as stated on its certificate of analysis (COA), or your order was not handled correctly, you get a full refund. The 60 days is your window to verify us, not a shelf life. The guarantee is on product quality, never on a health outcome.

Study Protocol Reference, Included

Every order includes a written reference to the dose ranges published studies used, with the study named, plus support at no extra cost. This is not a prescription; consult a licensed physician.

Direct WhatsApp Access

Every order includes direct access to our support team. Questions about certificates, reconstitution, storage, shipping or an order, message us any time and a real person responds.

400+

Customers served

Consistently rated by our customers

See the Lumen stack

Quality guarantee: full refund on any purity failure. All sales otherwise final. The 60-day money back guarantee covers product purity, certificate of analysis, and fulfillment. It is not conditioned on any outcome and does not promise one. This is educational information, not medical advice; consult a licensed physician.

Also in a stack

Tirzepatide is in a research stack

A stack groups catalog compounds from one research area and is priced at 35 percent off their combined retail. It is a grouping for browsing related research, not a protocol, and no stack has been tested as a combination.

Lumen stack

Weight & body composition research

Tirzepatide research vial from Peptara LabsBPC-157 research vial from Peptara LabsGHK-Cu research vial from Peptara Labs

Tirzepatide ×2, BPC-157, GHK-Cu, Glutathione

$401$617save $2165 vials, 35% off combined retail
See the Lumen stack →

Research and citations

Peer-reviewed sources

  1. Jastreboff AM, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. doi.org/10.1056/NEJMoa2206038
  2. Aronne LJ, et al. (2024). Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4). JAMA. doi.org/10.1001/jama.2023.24945

Citations refer to the peer-reviewed publications these figures are taken from. Every dose range reported on this site is the range a named study used. Not a substitute for medical advice.

Tirzepatide FAQ

Ordering from Vietnam? See price and delivery

Order Tirzepatide, 20mg vial

Order Tirzepatide today. Worldwide shipping, 5 to 10 business days, guaranteed.

Single vials are sold out. Tirzepatide is available in the Lumen research stack. See the stack

Certificate of analysis included · Order support on WhatsApp · Tracked worldwide shipping

For research and educational purposes only. Peptara Labs is not a medical provider and this is not medical advice. These statements and products have not been evaluated by the FDA or any equivalent regulator and are not intended to diagnose, treat, cure, or prevent any disease. Consult a licensed physician before use. See our Medical Disclaimer and Terms.